Neuropsychological status of subjects at high risk for a first episode of psychosis
暂无分享,去创建一个
T. McGlashan | S. Woods | B. Christensen | D. Perkins | K. Hawkins | R. Keefe | J. Addington | A. Breier | T. J. Miller | J. Addington | S. W. Woods | K. A. Hawkins | E. Marquez | A. Breier | T. H. McGlashan | T. Miller | R.S.E. Keefe | B. Christensen | D. O. Perkins | R. Zipurksy | J. Addington | E. Marquez | R. Zipurksy | S. Woods
[1] K. Hawkins. Indicators of Brain Dysfunction Derived from Graphic Representations of the WAIS-III/WMS-III Technical Manual Clinical Samples Data: A Preliminary Approach to Clinical Utility , 1998 .
[2] J. O. Johannessen,et al. Early detection and intervention with schizophrenia: rationale. , 1996, Schizophrenia bulletin.
[3] Barbara A. Cornblatt,et al. The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients , 1989, Psychiatry Research.
[4] B. Cornblatt,et al. Update of high-risk research: 1987-1997 , 1997 .
[5] D. Tulsky,et al. WAIS-III WMS-III Discrepancy Analysis: Six-Factor Model Index Discrepancy Base Rates, Implications, and a Preliminary Consideration of Utility , 2003 .
[6] M. Åsberg,et al. A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.
[7] T. Goldberg,et al. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. , 1997, Archives of general psychiatry.
[8] Terry E. Goldberg,et al. Verbal fluency deficits in patients with schizophrenia: Semantic fluency is differentially impaired as compared with phonologic fluency , 1996 .
[9] T. McGlashan. Treating schizophrenia earlier in life and the potential for prevention , 2003, Current psychiatry reports.
[10] I. Falloon,et al. Early intervention for first episodes of schizophrenia: a preliminary exploration. , 1992, Psychiatry.
[11] D. Braff,et al. Neuropsychological functioning and time-linked information processing in schizophrenia. , 1991 .
[12] T. McGlashan,et al. Early detection and intervention in schizophrenia: editor's introduction. , 1996, Schizophrenia bulletin.
[13] R. Keefe,et al. Test–Retest Reliability of the Dot Test of Visuospatial Working Memory in Patients with Schizophrenia and Controls , 2000, Schizophrenia Research.
[14] Larry J. Seidman,et al. Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia , 1994, Biological Psychiatry.
[15] T. Sharma,et al. Neuropsychological functioning in first-episode psychosis — evidence of specific deficits , 2000, Schizophrenia Research.
[16] M. Franzen,et al. Effects of practice and differential instructions on Stroop performance. , 1988 .
[17] Verbal IQ-performance IQ differentials in traumatic brain injury samples. , 2002, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[18] J. Ragland,et al. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. , 1990, Archives of general psychiatry.
[19] R. Hoffman,et al. Cognition, negative symptoms, and diagnosis: a comparison of schizophrenic, bipolar, and control samples. , 1997, The Journal of neuropsychiatry and clinical neurosciences.
[20] T. McGlashan,et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. , 2002, The American journal of psychiatry.
[21] O. Spreen,et al. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1991 .
[22] S. Woods,et al. Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia? , 1999, Psychological Medicine.
[23] Christie Golden,et al. Stroop Color and Word Test: Manual for Clinical and Experimental Uses. , 1978 .
[24] R. Reitan,et al. The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation , 1993 .
[25] Satterthwaite Fe. An approximate distribution of estimates of variance components. , 1946 .
[26] J. Lieberman,et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. , 2000, The American journal of psychiatry.
[27] R. C. Young,et al. A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.
[28] R. Keefe,et al. Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay , 1997, Schizophrenia Research.
[29] R. Hoffman,et al. Symptom Assessment in Schizophrenic Prodromal States , 2004, Psychiatric Quarterly.
[30] T. McGlashan,et al. Diagnosis and symptom assessment in the schizophrenia prodrome , 2003, Schizophrenia Research.
[31] R J Wyatt,et al. Neuroleptics and the natural course of schizophrenia. , 1991, Schizophrenia bulletin.
[32] N. Risch,et al. The continuous performance test, identical pairs version (CPT-IP): I. new findings about sustained attention in normal families , 1988, Psychiatry Research.
[33] R. Ivnik,et al. Clinical Interpretation of the WAIS-III and WMS-III , 2003 .
[34] G. W. Snedecor. Statistical Methods , 1964 .
[35] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[36] J. Reddon,et al. Normative data stratified by age and sex for 12 neuropsychological tests , 1986 .
[37] A. Wiens,et al. California verbal learning test: A normative data study , 1994 .
[38] Robert W. McCarley,et al. A neuropsychological analysis of schizophrenic thought disorder , 1998, Schizophrenia Research.
[39] V. Bowden,et al. The Journal of Neuropsychiatry and Clinical Neurosciences , 1992 .
[40] A. Benton. Contributions to Neuropsychological Assessment: A Clinical Manual , 1983 .
[41] D. Linszen,et al. Early detection and intervention in schizophrenia , 1998, International clinical psychopharmacology.
[42] R. Hoffman,et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis I. Study rationale and design , 2003, Schizophrenia Research.
[43] Adrian Preda,et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis II. Baseline characteristics of the “prodromal” sample , 2003, Schizophrenia Research.
[44] B. Wexler,et al. California Verbal Learning Test practice effects in a schizophrenia sample , 1999, Schizophrenia Research.
[45] S. Faraone,et al. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a 4-year follow-up study. , 1999, Journal of abnormal psychology.